Literature DB >> 22428546

Gene therapy approaches for lysosomal storage disorders, a good model for the treatment of mendelian diseases.

Rosella Tomanin1, Alessandra Zanetti, Eva Zaccariotto, Francesca D'Avanzo, Cinzia M Bellettato, Maurizio Scarpa.   

Abstract

UNLABELLED: This review describes the different gene therapy technologies applied to approach lysosomal storage disorders, monogenic conditions, with known genetic and biochemical defects, for many of which animal models are available. Both viral and nonviral procedures are described, underlying the specific needs that the treatment of genetic disorders requires.
CONCLUSIONS: Lysosomal storage disorders represent a good model of study of gene therapeutic procedures that are, or could be, relevant to the treatment of several other mendelian diseases.
© 2012 The Author(s)/Acta Paediatrica © 2012 Foundation Acta Paediatrica.

Entities:  

Mesh:

Year:  2012        PMID: 22428546     DOI: 10.1111/j.1651-2227.2012.02674.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  10 in total

Review 1.  Gene therapy for the neurological manifestations in lysosomal storage disorders.

Authors:  Seng H Cheng
Journal:  J Lipid Res       Date:  2014-03-29       Impact factor: 5.922

Review 2.  Blood-brain barrier structure and function and the challenges for CNS drug delivery.

Authors:  N Joan Abbott
Journal:  J Inherit Metab Dis       Date:  2013-04-23       Impact factor: 4.982

Review 3.  Blood-brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders.

Authors:  Hema Kumari Alajangi; Mandeep Kaur; Akanksha Sharma; Sumedh Rana; Shipali Thakur; Mary Chatterjee; Neha Singla; Pradeep Kumar Jaiswal; Gurpal Singh; Ravi Pratap Barnwal
Journal:  Mol Brain       Date:  2022-06-01       Impact factor: 4.399

Review 4.  Sphingolipid lysosomal storage disorders.

Authors:  Frances M Platt
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

5.  Partial correction of the CNS lysosomal storage defect in a mouse model of juvenile neuronal ceroid lipofuscinosis by neonatal CNS administration of an adeno-associated virus serotype rh.10 vector expressing the human CLN3 gene.

Authors:  Dolan Sondhi; Emma C Scott; Alvin Chen; Neil R Hackett; Andrew M S Wong; Agnieszka Kubiak; Hemanth R Nelvagal; Yewande Pearse; Susan L Cotman; Jonathan D Cooper; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2014-03-04       Impact factor: 5.695

6.  Murine neural stem cells model Hunter disease in vitro: glial cell-mediated neurodegeneration as a possible mechanism involved.

Authors:  E Fusar Poli; C Zalfa; F D'Avanzo; R Tomanin; L Carlessi; M Bossi; L Rota Nodari; E Binda; P Marmiroli; M Scarpa; D Delia; A L Vescovi; L De Filippis
Journal:  Cell Death Dis       Date:  2013-11-07       Impact factor: 8.469

Review 7.  Drug delivery in overcoming the blood-brain barrier: role of nasal mucosal grafting.

Authors:  Carlotta Marianecci; Federica Rinaldi; Patrizia Nadia Hanieh; Luisa Di Marzio; Donatella Paolino; Maria Carafa
Journal:  Drug Des Devel Ther       Date:  2017-01-27       Impact factor: 4.162

Review 8.  The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction.

Authors:  Frances M Platt; Barry Boland; Aarnoud C van der Spoel
Journal:  J Cell Biol       Date:  2012-11-26       Impact factor: 10.539

Review 9.  Possible strategies to cross the blood-brain barrier.

Authors:  Cinzia M Bellettato; Maurizio Scarpa
Journal:  Ital J Pediatr       Date:  2018-11-16       Impact factor: 2.638

Review 10.  Sanfilippo Syndrome: Molecular Basis, Disease Models and Therapeutic Approaches.

Authors:  Noelia Benetó; Lluïsa Vilageliu; Daniel Grinberg; Isaac Canals
Journal:  Int J Mol Sci       Date:  2020-10-22       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.